T2 Biosystems, Inc. (TTOO)
OTCMKTS · Delayed Price · Currency is USD
0.0025
+0.0010 (66.67%)
Sep 18, 2025, 10:04 AM EDT
T2 Biosystems Company Description
T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare.
Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.
T2 Biosystems, Inc.
| Country | United States |
| Founded | 2006 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 113 |
| CEO | Craig Jalbert |
Contact Details
Address: 101 Hartwell Avenue Lexington, Delaware 02421 United States | |
| Phone | 781 761 4646 |
| Website | investors.t2biosystems.com |
Stock Details
| Ticker Symbol | TTOO |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US89853L1044 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Craig R. Jalbert CIRA | Chief Executive Officer, President, Corporate Treasurer, Corporate Secretary and Director |
| Kelley J. Morgan | Chief People Officer |
| Brett A. Giffin | Chief Commercial Officer |
| Dr. Roger Smith Ph.D. | Senior Vice President of Science Research and Development |